Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rats

This publication has 19 references indexed in Scilit:

• Mobilization of heavy metals by newer, therapeutically useful chelating agents
  Toxicology, 1995
• Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. A review
  The Analyst, 1995
• Childhood Lead Poisoning and its Treatment
  Annual Review of Pharmacology and Toxicology, 1993
• Antidotal effects of dimercaptosuccinic acid
  Journal of Applied Toxicology, 1991
• Influence of 2,3 dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors
  Toxicology, 1989
• The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning
  JAMA, 1986
• BAL increases the arsenic-74 content of rabbit brain
  Toxicology and Applied Pharmacology, 1983
• DMSA and DMPS-Water Soluble Antidotes for Heavy Metal Poisoning
  Annual Review of Pharmacology and Toxicology, 1983
• The effect of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the distribution and excretion of mercuric chloride in rats
  Toxicology, 1981
• Accelerated Uptake of Mercury by Brain caused by 2,3‐ Dimercaptopropanol (BAL) After Injection into the Mouse of a Methylmercuric Compound
  Acta Pharmacologica et Toxicologica, 1965